Charles River Laboratories
CRL
#1388
Rank
NZ$27.48 B
Marketcap
NZ$573.67
Share price
-4.15%
Change (1 day)
99.26%
Change (1 year)
Categories

Earnings for Charles River Laboratories (CRL)

Earnings in 2026 (TTM): -NZ$0.17 Billion

According to Charles River Laboratories 's latest financial reports the company's current earnings are NZ$3.97 Billion. In 2025 the company made an earning of -NZ$0.19 Billion a decrease over its 2024 earnings that were of NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Charles River Laboratories from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.17 Billion-10.09%
2025 -NZ$0.19 Billion-206.86%
2024 NZ$0.16 B-83.98%
2023 NZ$1.06 B-6.69%
2022 NZ$1.13 B29.6%
2021 NZ$0.87 B7.51%
2020 NZ$0.81 B47.04%
2019 NZ$0.55 B7.95%
2018 NZ$0.51 B-5.14%
2017 NZ$0.54 B33.21%
2016 NZ$0.40 B14.07%
2015 NZ$0.35 B10.04%
2014 NZ$0.32 B28.39%
2013 NZ$0.25 B6.61%
2012 NZ$0.23 B-2.2%
2011 NZ$0.24 B-140.16%
2010 -NZ$0.61 Billion-321.56%
2009 NZ$0.27 B-131.92%
2008 -NZ$0.86 Billion-314.85%
2007 NZ$0.39 B23.14%
2006 NZ$0.32 B10.82%
2005 NZ$0.29 B4.46%
2004 NZ$0.27 B15%
2003 NZ$0.24 B15.93%
2002 NZ$0.20 B64.66%
2001 NZ$0.12 B163.31%
2000 NZ$48.15 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
NZ$14.41 B-7,982.13%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-NZ$18.68 Million-89.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$55.99 M-130.61%๐Ÿ‡บ๐Ÿ‡ธ USA